Non-alcoholic steatohepatitis - A new epidemic;Die nicht-alkoholische steato-hepatitis - Eine neue epidemie

Praxis

Volumn 96, Issue 47, 2007, Pages 1857-1860

  Maier, K P ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Diagnosis; Non alcoholic hepatitis; Pathogenesis; Prognosis; Treatment

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; EPIDEMIC; FATTY LIVER; HUMAN; HYPERLIPIDEMIA; MOUSE; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS;

ANIMALS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIAGNOSIS, DIFFERENTIAL; DISEASE OUTBREAKS; FATTY LIVER; HUMANS; HYPERLIPIDEMIAS; MICE; OBESITY; PROGNOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36749096944     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/1661-8157.96.47.1857     Document Type: Review

References (11)

1. U.Leuschner, Ätiologie und Pathogenese der nichtalkoholischen Steatohepatitis. In: Fettleber und Fettleberhepatitis - NASH und ASH, UNI-MED, Bremen 2003; 52-6
2. Uysal K.T. et al., Protection from obesity-induced insulin resistance in mice lacking TNF-a-function, Nature 1997; 389:610-61
3. Harrison S.A. et al., Orlistat treatment in obese, non-alcoholic steatohepatitis patients: a pilot study, Hepatology 2002; 36: 406
4. Marchesini G. et al., Metformin in non-alcoholic steatohepatitis, Lancet 2001; 358: 893-4 (Pubitemid 32900577)
5. Levine J.A. et al., Interindividual variation in posture allocation: possible role in human obesity. Science 2005; 307: 584-6 (Pubitemid 40165681)
6. Wanless I.R. et al., Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatologiy 1990; 12: 1106-10
7. Falck-Ytter Y. In: Nonalcoholic steatosis syndromes. Gores G., Lindor K. (edts). Sem. Liv. Dis., 21; 2001: 17
8. Adams A. et al., NASH: a hidden and silent fibroser finally revealed? J Hepatol 2005; 42: 12-4
9. McCullough A.J. In: Steatohepatitis: Leuschner U., James O.F.W., Dancygier H. (edts). Kluwer Academic Publishers, 2001,:11
10. Dixon J.B. et al., Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology 2004; 39: 1647-54 (Pubitemid 38702666)
11. Promrat K. et al., A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 2004; 39: 188-96 (Pubitemid 38461481)